title: Does antiretroviral-induced hyperlipidaemia constitute a cardiovascular risk?
authors.affiliation: Chelsea and Westminster Hospital, London SW10 9NH, UK.
authors.forename: Y
authors.initials: Y
authors.lastname: Gilleece
authors.forename: M
authors.initials: M
authors.lastname: Nelson
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology*; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced* / Q000150:complications; D015994:Incidence; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects; D012307:Risk Factors; D017211:Treatment Failure
chemical_list: D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors